EANS-News: Balda AG receives request to convene an Extraordinary General Meeting (with document)
03.04.2013 – 18:45
-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Company Information Bad Oeynhausen (euro adhoc) - Bad Oeynhausen, 3 April 2013 - Balda AG announces that today it received a request from the shareholder Elector GmbH, Berlin, Germany, to convene an Extraordinary General Meeting in accordance with Section 122 (1) of the German Stock Corporation Act (AktG). The purpose of this meeting will be to completely replace its three-member Supervisory Board with the removal of the Supervisory Board Chairman, Dr. Michael Naschke, and the election of rival candidates for the Supervisory Board members Irene Schetelig and Wilfried Niemann. The request for Dr. Michael Naschke's removal from office is motivated inter alia by the fact that he, along with the other two acting Supervisory Board members, had approved the Management Board's proposal to pay a special dividend of EUR 1.50 for the current financial year 2012/2013. The Management Board will examine the legal aspects of the request comprehensively before deciding what action to take. Dr. Michael Naschke's Supervisory Board position had been confirmed at the Annual General Meeting of Balda AG on 7 November 2012 with 88% of the vote. As announced by Balda AG, on 22 February 2013 the Bad Oeynhausen Local Court appointed Ms. Schetelig and Mr. Niemann as independent Supervisory Board members at the company's request after two Supervisory Board members had resigned from office with effect from 28 February 2013. The Local Court had rejected the request from Elector GmbH to appoint two of its own candidates, Dr. Thomas van Aubel, managing partner of the shareholder Elector GmbH, and Ms. Frauke Vogler, on the grounds of these candidates' lack of independence. Elector GmbH is proposing that the Extraordinary General Meeting elect the following candidates for the Supervisory Board positions: Dr. Thomas van Aubel, Ms. Frauke Vogler and Mr. Oliver Oechsle. About Balda Balda is a provider of first-class solutions for demanding, high-quality applications in the fields of medical technology, optics, the automotive industry and other specialist industrial sectors. The Group's Balda Medical and Balda Technical operating divisions have operations worldwide, and the company maintains production facilities in Germany, the USA and Malaysia. The success of Balda, which employs more than 1,700 people, is based on the deployment of leading-edge, cost-effective technologies, coupled with the trust-based collaboration with customers. The Balda AG share (ISIN: DE0005215107) is listed on the SDAX segment of Deutsche Börse. www.balda.de www.balda-medical.de Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/ddPQXPLE Further inquiry note: Kontakt/Ansprechpartner: Frank Elsner Frank Elsner Kommunikation für Unternehmen GmbH Tel.: +49 - 54 04 - 91 92 0 Fax: +49 - 54 04 - 91 92 29 Mail:office@elsner-kommunikation.de end of announcement euro adhoc -------------------------------------------------------------------------------- Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/ddPQXPLE company: Balda Aktiengesellschaft Bergkirchener Str. 228 D-32549 Bad Oeynhausen phone: +49 (0) 5734 9 22-0 FAX: +49 (0) 5734 922-2604 mail: info@balda.de WWW: http://www.balda.de sector: Semiconductors & active components ISIN: DE0005215107 indexes: SDAX, Prime All Share stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English